Besides, the downregulation of FXR by siRNA or its inhibition by its natural antagonist, guggulsterone, resulted in the suppression of NF-κB activity and its regulated target vascular endothelial growth factor (VEGF), which lead to decreased cell proliferation, invasion and migration of pancreatic cancer cells. The gene discussed is NFKB1; the disease is pancreatic neoplasm.